|Bid||6.24 x 800|
|Ask||6.25 x 1400|
|Day's range||6.22 - 6.53|
|52-week range||5.85 - 18.98|
|Beta (5Y monthly)||3.14|
|PE ratio (TTM)||N/A|
|Earnings date||09 Feb 2022 - 14 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||6.58|
In particular, Aurora Cannabis (NASDAQ: ACB) and Hexo (NASDAQ: HEXO) are two underperforming companies that are working to reposition themselves to become more stable and successful. Can Aurora follow through on its transformation plan? Aurora Cannabis has been struggling for quite some time, and it's in the midst of an ambitious business transformation plan that aims to slash its costs and right-size the company.
U.S. legalization is still stalled, but Mexican marijuana legalization could be imminent.
Canadian pot producers Aurora Cannabis (NASDAQ: ACB) and Canopy Growth (NASDAQ: CGC) have been rivals for years. For the period ending Sept. 30, Canopy Growth reported revenue of 131.4 million Canadian dollars ($104 million). The company noted "continued price compression" in the Canadian market and more competition in international markets as some of the reasons its revenue hasn't been particularly strong of late.